Related Experiment Video
Updated: May 13, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Evidence base in guideline generation in diabetes
1Unit of Health Sciences and Education, University of Hamburg, Martin-Luther-King Platz 6, 20146, Hamburg, Germany. Ingrid_Muehlhauser@uni-hamburg.de
Clinical practice guidelines (CPGs) vary in quality, often lacking patient-centeredness and clear decision-making information. Financial conflicts of interest (COI) are prevalent, necessitating independent methodologists for guideline development.
Area of Science:
- Medical Informatics
- Health Services Research
- Evidence-Based Medicine
Background:
- Clinical practice guidelines (CPGs) are crucial for evidence-based medicine but exhibit significant variability in methodological quality.
- Key contemporary concerns include patient-centeredness, shared decision-making, and financial conflicts of interest (COI) in CPG development.
Purpose of the Study:
- To critically evaluate patient-centeredness and COI in current CPGs.
- To identify areas for improvement in CPG development to enhance clinical applicability and patient benefit.
Main Methods:
- Review of current literature and practices concerning CPG development.
- Analysis of patient involvement strategies and conflict of interest policies in CPGs.
Main Results:
- CPGs often fail to meet patient needs by not providing accessible summaries of treatment benefits and risks.
- A majority of CPG panels report financial COI, with frequent under-reporting and inconsistent organizational policies.
- Current patient involvement methods do not fully substitute for individual patient preferences in clinical decisions.
Conclusions:
- Enhancing patient-centeredness and transparency regarding COI are critical for improving CPG quality.
- Independent methodologists and shared data platforms (e.g., EASD clearing house) are recommended to mitigate bias and resource waste in CPG development.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Introduction
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology